Macular Corneal Dystrophy: An Updated Review
Shalini Singh, Sujata Das, Chitra Kannabiran, Saumya Jakati, Sunita Chaurasia
Abstract
gene, which results in abnormal proteoglycan synthesis. There is accumulation of abnormal glycosaminoglycans in the corneal stroma and endothelium. The deposition results in progressive loss of corneal transparency and visual acuity. The histopathology shows characteristic alcian blue positive deposits. Management in the cases with visual loss requires keratoplasty either full thickness or lamellar. The decision about the ideal type of keratoplasty depends on age and pre-operative clinical features. Although prognosis after keratoplasty is good, recurrences can occur. Future research should be targeted towards gene therapy in this condition.
Topics & Concepts
Corneal dystrophyOphthalmologyMedicineDystrophyVisual acuityStromaHistopathologyCorneal endotheliumCorneaPathologyImmunohistochemistryCorneal Surgery and TreatmentsCorneal surgery and disordersOcular Surface and Contact Lens